ABOUT US
About AmoyDx History Certificates News & Events Staff Charisma Stock Information
PRODUCTS
NGS Assays Real-time PCR Assays FISH Assays Extraction
GLOBAL BUSINESS
Distributorship
SUPPORT
Customer Service
FAQs
DOWNLOAD
MEET US
MEET US
language
Search
COVID19 NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
Log in
Log in
Search
COVID19 NTRK HRR HANDLE Classic NGS Panel Pan Lung Cancer Essential NGS panel BRCA Multi-Gene Super-ARMS EGFR C797S KRAS NRAS ROS1 MET HPV
ABOUT US PRODUCTS GLOBAL BUSINESS SUPPORT MEET US
  • Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
08 /Jul

AmoyDx Signs Agreement with AstraZeneca to Cooperate in Cancer Diagnosis in China

Xiamen, China, 8 July, 2020– Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that recently it signed an agreement with AstraZeneca to work together closely for the molecular diagnosis of patients with cancer.

22 /May

AmoyDx Collaborates with Amgen to Develop Companion Diagnostics for China Market

Xiamen, China, 22 May, 2020– Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with Amgen Inc. to develop Companion Diagnostic (CDx) tests supporting an investigational molecule within Amgen’s oncology portfolio. The

24 /Mar

AmoyDx Announces Research Collaboration with Janssen to Develop Companion Diagnostics for China Market

Xiamen, China, 24 March, 2020–Amoy Diagnostics Co., Ltd. (AmoyDx, SZSE: 300685) announced that it signed an agreement with Janssen (China) Research & Development Center, a Division of Johnson & Johnson (China) Investment Ltd., to develop an oncology compa

14 /Mar

Latest News: Amoy Diagnostics born another clinical detecting center

Shanghai Xiawei Biotechnology Co. Laboratory (hereinafter referred to as "Shanghai Xiawei") under Amoy Diagnostics passed the examination of Shanghai Municipal Health Commission and was granted the "Practice License for Medical Institutions".

more

New Products

new product release

    New Products

    new product release

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • NGS HANDLE HRR NGS Panel
      06
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • NGS HANDLE HRR NGS Panel
      06
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • NGS HANDLE HRR NGS Panel
      06
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06

    • AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit

    • NTRK Gene Fusions Detection Kit

    • Pan Lung Cancer PCR Panel

    • HANDLE Classic NGS Panel

    • BRCA1 and BRCA2 Gene Mutation Detection Kit

    • HANDLE HRR NGS Panel

    • PCR AmoyDx® Novel Coronavirus (2019-nCoV) Detection Kit
      01
    • PCR NTRK Gene Fusions Detection Kit
      02
    • PCR Pan Lung Cancer PCR Panel
      03
    • NGS HANDLE Classic NGS Panel
      04
    • NGS BRCA1 and BRCA2 Gene Mutation Detection Kit
      05
    • NGS HANDLE HRR NGS Panel
      06
    1. 01
    2. 02
    3. 03
    4. 04
    5. 05
    6. 06
  1. NGS
  2. PCR
  3. FISH
  4. Extraction
    5. more
Support

World Conference on Lung Cancer 2020

https://wclc2020.iaslc.org/

January 26 – 29, 2021
meet us

AMP Annual(Association for Molecular Pathology) 2020

https://amp20.amp.org/

November 19-21, 2020

  • Stock Info

    Stock info
  • 74.100 +0.5 +0.68％
    Stock code：300685 2020-07-10 15:00:03 Real-time data
  • View details
Inquiry
* Required information
Refresh the image
send
Manage your account info
  • Please Select
  • Mr.
  • Ms.
  • Dr.
  • Prof.
Submit
Change your password
Confirm Submission